RCM
RA Capital Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,878,000
| Closed | -$17.6M | – | 89 |
|
|
2024
Q4 | $17.6M | Hold |
4,878,000
| – | – | 0.23% | 61 |
|
|
2024
Q3 | $27.8M | Hold |
4,878,000
| – | – | 0.32% | 49 |
|
|
2024
Q2 | $22.5M | Hold |
4,878,000
| – | – | 0.3% | 51 |
|
|
2024
Q1 | $39.9M | Hold |
4,878,000
| – | – | 0.51% | 45 |
|
|
2023
Q4 | $27.6M | Buy |
+4,878,000
| New | +$27.6M | 0.43% | 41 |
|
|
2022
Q1 | – | Sell |
-1,377,569
| Closed | -$44.4M | – | 98 |
|
|
2021
Q4 | $44.4M | Hold |
1,377,569
| – | – | 0.78% | 38 |
|
|
2021
Q3 | $61.6M | Hold |
1,377,569
| – | – | 0.85% | 35 |
|
|
2021
Q2 | $52.1M | Hold |
1,377,569
| – | – | 0.84% | 39 |
|
|
2021
Q1 | $51M | Hold |
1,377,569
| – | – | 0.77% | 39 |
|
|
2020
Q4 | $45.6M | Buy |
+1,377,569
| New | +$45.6M | 0.64% | 42 |
|